Literature DB >> 21466815

Contributions of serotonin in addiction vulnerability.

L G Kirby1, F D Zeeb, C A Winstanley.   

Abstract

The serotonin (5-hydroxytryptamine; 5-HT) system has long been associated with mood and its dysregulation implicated in the pathophysiology of mood and anxiety disorders. While modulation of 5-HT neurotransmission by drugs of abuse is also recognized, its role in drug addiction and vulnerability to drug relapse is a more recent focus of investigation. First, we review preclinical data supporting the serotonergic raphe nuclei and their forebrain projections as targets of drugs of abuse, with emphasis on the effects of psychostimulants, opioids and ethanol. Next, we examine the role of 5-HT receptors in impulsivity, a core behavior that contributes to the vulnerability to addiction and relapse. Finally, we discuss evidence for serotonergic dysregulation in comorbid mood and addictive disorders and suggest novel serotonergic targets for the treatment of addiction and the prevention of drug relapse.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466815      PMCID: PMC3110503          DOI: 10.1016/j.neuropharm.2011.03.022

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  226 in total

1.  A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.

Authors:  M Shankaran; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls.

Authors:  Anna E Goudriaan; Jaap Oosterlaan; Edwin de Beurs; Wim van den Brink
Journal:  Brain Res Cogn Brain Res       Date:  2005-04

3.  The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.

Authors:  M Carli; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

4.  Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.

Authors:  B Gough; S F Ali; W Slikker; R R Holson
Journal:  Pharmacol Biochem Behav       Date:  1991-07       Impact factor: 3.533

5.  mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding.

Authors:  A Mansour; C A Fox; R C Thompson; H Akil; S J Watson
Journal:  Brain Res       Date:  1994-04-18       Impact factor: 3.252

Review 6.  Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine.

Authors:  S L Walsh; K A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1997-03       Impact factor: 4.530

7.  The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.

Authors:  Marleen Wingen; Kim P C Kuypers; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2006-11-24       Impact factor: 4.530

8.  Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats.

Authors:  Jennifer L Perry; Erin B Larson; Jonathan P German; Gregory J Madden; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.

Authors:  T D Steele; D E Nichols; G K Yim
Journal:  Biochem Pharmacol       Date:  1987-07-15       Impact factor: 5.858

10.  Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  Sanna Kurling; Aino Kankaanpää; Timo Seppälä
Journal:  Behav Brain Res       Date:  2008-01-05       Impact factor: 3.332

View more
  68 in total

Review 1.  Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules.

Authors:  Taylor Wingo; Tanseli Nesil; Jung-Seok Choi; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-19       Impact factor: 4.147

Review 2.  Neural circuitry and mechanisms of waiting impulsivity: relevance to addiction.

Authors:  Jeffrey W Dalley; Karen D Ersche
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

3.  Pharmacological evidence that 5-HT2C receptor blockade selectively improves decision making when rewards are paired with audiovisual cues in a rat gambling task.

Authors:  Wendy K Adams; Chris Barkus; Jacqueline-Marie N Ferland; Trevor Sharp; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2017-07-21       Impact factor: 4.530

4.  Neurochemical profiles of some novel psychoactive substances.

Authors:  Les Iversen; Simon Gibbons; Ric Treble; Vincent Setola; Xi-Ping Huang; Bryan L Roth
Journal:  Eur J Pharmacol       Date:  2012-12-21       Impact factor: 4.432

Review 5.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 6.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

Review 7.  Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.

Authors:  Nicole M Enman; Yong Zhang; Ellen M Unterwald
Journal:  Pharmacol Biochem Behav       Date:  2013-12-11       Impact factor: 3.533

8.  The CC genotype in the T102C HTR2A polymorphism predicts relapse in individuals after alcohol treatment.

Authors:  Andrzej Jakubczyk; Anna Klimkiewicz; Maciej Kopera; Aleksandra Krasowska; Małgorzata Wrzosek; Halina Matsumoto; Margit Burmeister; Kirk J Brower; Marcin Wojnar
Journal:  J Psychiatr Res       Date:  2013-01-12       Impact factor: 4.791

Review 9.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 10.  Reducing substance use during adolescence: a translational framework for prevention.

Authors:  Jessica J Stanis; Susan L Andersen
Journal:  Psychopharmacology (Berl)       Date:  2014-01-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.